Navidea Biopharmaceuticals Announces $1.9 Million Private Placement

Dec 6, 2019

Navidea Biopharmaceuticals to Present at the 12th Annual LD Micro Main Event

Dec 5, 2019

Navidea Biopharmaceuticals Wins Summary Judgment in Ohio

Dec 2, 2019

Navidea Biopharmaceuticals to Present at the PCG Spotlight Series Conference

Nov 14, 2019

Navidea Biopharmaceuticals Reports Third Quarter 2019 Financial Results

Nov 7, 2019

Navidea Biopharmaceuticals Announces Preclinical Therapeutic Research Collaboration with IMV Inc. to Explore the Potential Combinatory Effect with Their Platform-Based Immunotherapies

Nov 7, 2019

Navidea Biopharmaceuticals to Host Third Quarter 2019 Earnings Conference Call and Corporate Update

Oct 31, 2019

Navidea Biopharmaceuticals Announces Positive Results of First Interim Analysis of Ongoing Phase 2B Study in Rheumatoid Arthritis

Oct 29, 2019

Navidea Biopharmaceuticals to Present at the H.C. Wainwright 21st Annual Global Investment Conference

Sep 6, 2019

Navidea Biopharmaceuticals Announces Receipt of Notice of Award

Aug 27, 2019